As of November 27, 2025, 48 million shares of our common stock were available for future awards under our equity compensation plans, including 7 million shares approved for issuance under our employee stock purchase plan (“ESPP”).

Restricted Stock and Restricted Stock Units (“Restricted Stock Awards”)


Three months ended	November 27, 2025		November 28, 2024

Restricted stock award shares granted	6		10
Weighted-average grant-date fair value per share	$	210.15	$	100.95

Stock-based compensation expense recognized in our statements of operations is presented below. Stock-based compensation expense of $106 million and $96 million was capitalized and remained in inventory as of November 27, 2025 and August 28, 2025, respectively.


Three months ended	November 27, 2025		November 28, 2024

Stock-based compensation expense by caption
Cost of goods sold	$	107	$	90
Research and development	106		77
Selling, general, and administrative	67		50
	$	280	$	217

Stock-based compensation expense by type of award
Restricted stock awards	$	252	$	192
ESPP	28		25
	$	280	$	217

As of November 27, 2025, $2.57 billion of total unrecognized compensation costs for unvested awards, before the effect of any future forfeitures, was expected to be recognized through the first quarter of 2030, resulting in a weighted-average period of 1.4 years.